Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alpine Immune Sciences Inc (ALPN)
NASDAQ:ALPN
Alpine Immune Sciences (ALPN) Ownership - Who Owns Alpine Immune Sciences?
439 Followers
Alpine Immune Sciences (ALPN) Ownership Overview
52.43% Insiders
9.26% Mutual Funds
12.80% Other Institutional Investors
25.51% Public Companies and
Individual Investors
The ownership structure of Alpine Immune Sciences (ALPN) stock is a mix of institutional, retail and individual investors. Approximately 22.06% of the company’s stock is owned by Institutional Investors, 52.43% is owned by Insiders and 25.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 22, 2024 | Xiangmin Cui Director, >10% Owner | Bought | $15729263 |
| Jan 22, 2024 | Bought | $15729263 | |
| Jan 16, 2024 | Peter A. Thompson Director | Bought | $1850498 |
| Jan 16, 2024 | Orbimed Advisors Llc Director | Bought | $1850498 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $2039 | |
| Dec 31, 2023 | Bought | $449167 | |
| Dec 31, 2023 | Sold | $19062020 | |
| Dec 31, 2023 | Bought | $93580082 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,909,763 | Institution | 7.49% | 316,974,299 | |
| 2,541,903 | Institution | 3.88% | 164,105,258 | |
| 1,966,081 | Institution | 3.00% | 126,930,189 | |
| 1,892,836 | Institution | 2.89% | 122,201,492 | |
| 1,844,404 | Institution | 2.81% | 119,074,722 | |
| 1,105,737 | Institution | 1.69% | 71,386,381 | |
| 1,000,106 | Institution | 1.53% | 64,566,843 | |
| 394,000 | Institution | 0.60% | 25,436,640 | |
| 387,374 | Institution | 0.59% | 25,008,865 | |
| 380,659 | Institution | 0.58% | 24,575,345 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,844,404 | Institution | 2.81% | 119,074,722 | |
| 1,105,737 | Institution | 1.69% | 71,386,381 | |
| 394,000 | Institution | 0.60% | 25,436,640 | |
| 387,374 | Institution | 0.59% | 25,008,865 | |
| 380,659 | Institution | 0.58% | 24,575,345 | |
| 353,033 | Institution | 0.54% | 22,791,810 | |
| 326,166 | Institution | 0.50% | 21,057,277 | |
| 220,800 | Institution | 0.34% | 14,254,848 | |
| 213,300 | Institution | 0.33% | 13,770,648 | |
| 154,534 | Institution | 0.24% | 9,976,715 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,920,856 | Institution | 2.93% | 123,991,255 | |
| 1,573,587 | Institution | 2.40% | 62,376,989 | |
| 907,070 | Institution | 1.38% | 58,551,369 | |
| 677,149 | Institution | 1.03% | 26,842,186 | |
| 335,876 | Institution | 0.51% | 21,680,796 | |
| 210,436 | Institution | 0.32% | 13,583,644 | |
| 173,767 | Institution | 0.27% | 11,216,660 | |
| 166,894 | Institution | 0.25% | 10,773,008 | |
| 164,390 | Institution | 0.25% | 10,611,375 | |
| 112,432 | Institution | 0.17% | 7,243,994 |
FAQ
Who Owns Alpine Immune Sciences Inc (ALPN)?
According to the latest TipRanks data, approximately 12.80% of the company's stock is held by institutional investors, 52.43% is held by insiders, and 25.51% is held by retail investors.
What percentage of Alpine Immune Sciences Inc (ALPN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.80% of Alpine Immune Sciences Inc (ALPN) stock is held by institutional investors.
What percentage of Alpine Immune Sciences Inc (ALPN) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.51% of Alpine Immune Sciences Inc (ALPN) stock is held by retail investors.
Who owns the most shares of Alpine Immune Sciences Inc (ALPN)?
Peter Kolchinsky owns the most shares of Alpine Immune Sciences Inc (ALPN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.